Anal Fistula

Overview

An anal fistula is an abnormal tunnel-like channel that connects the inner lining of the anus to the skin surface around it. It develops when an infected anal gland forms an abscess that either drains spontaneously through the skin or is surgically drained, leaving behind a persistent tract that fails to close.

Anal fistulas typically begin with an anal abscess — a collection of pus that causes sudden, severe pain and swelling around the anus. After the abscess drains (either on its own or through surgery), the pain usually eases temporarily. However, if the drainage pathway does not heal and instead becomes a chronic channel lined with scar tissue, a fistula has formed. This happens in approximately 40 to 50 percent of anal abscesses.

The anatomy of a fistula can range from simple to highly complex. Simple fistulas follow a shallow, direct path that does not involve the sphincter muscles, while complex fistulas pass through or around the sphincter muscles and may have multiple branches or openings. This distinction is crucial both for choosing the right treatment and for protecting the patient's ability to control bowel movements (continence).

Anal fistulas can occur at any age but are most common in men between 30 and 40 years old. In the majority of cases, the underlying cause is a routine anal gland infection. However, Crohn's disease, tuberculosis, diverticulitis, and pelvic trauma can all predispose to fistula formation. Crohn's-related fistulas are particularly difficult to treat and prone to recurrence.

An anal fistula will not close on its own and always requires treatment. Left untreated, it can lead to chronic infection, recurrent abscesses, and in rare cases, malignant transformation.

Symptoms

The symptoms of an anal fistula vary with the size and location of the tract and whether active infection is present. Some patients experience mild, intermittent discomfort, while others live with persistent, distressing symptoms.

Anal fistula symptoms include the following:

• Discharge around the anus. This is the most frequent and most characteristic symptom. Purulent, bloody, or mucous discharge from the fistula opening stains underwear. The discharge occasionally stops, giving the misleading impression that the fistula has healed; in reality, this usually means the tract has temporarily blocked, which can herald a new abscess.
• Pain and tenderness around the anus. Aching or throbbing pain is most pronounced during active infection or when the fistula opening becomes blocked. Sitting, moving, and bowel movements typically worsen the pain. It may be constant or come and go in waves.
• Swelling and redness around the anus. The skin around the external opening may appear red, swollen, and tender to touch. When an active abscess is present, a distinct, warm, fluctuant swelling is often visible or palpable.
• Itching and irritation. Persistent discharge irritates the perianal skin and causes chronic itching. Over time, the skin may thicken and take on an eczema-like appearance.
• Pain during bowel movements. Defecation creates tension and pressure in the tissues surrounding the fistula, worsening pain. This can lead patients to defer bowel movements, which may compound constipation.
• Fever and general malaise. When active infection or a new abscess is forming within the tract, fever, chills, and fatigue may develop. These symptoms should be treated as a signal for urgent medical attention.

In some patients the external opening is directly visible as a small hole or red spot near the anus. In others, the external opening lies just beneath the skin and is only found on examination.

When to See a Doctor

The symptoms of an anal fistula can feel embarrassing and are often a reason to delay seeking help. However, this condition will not resolve on its own, and early consultation simplifies both diagnosis and treatment.

Schedule a medical evaluation if:

• You have noticed purulent or bloody discharge around the anus
• You have persistent or recurrent pain in the anal area
• You have previously had an anal abscess and similar symptoms have returned
• You have developed swelling, redness, or warmth around the anus
• You have a diagnosis of Crohn's disease and a new anal complaint has developed

Seek urgent medical attention if:

• High fever accompanies severe anal pain and swelling (this may indicate an abscess or necrotizing infection)
• A rapidly expanding, extremely tender, and red area develops around the anus
• Your general condition is deteriorating and you feel seriously unwell

Causes

The great majority of anal fistulas develop from an abscess caused by infection of an anal gland. These small glands, located just inside the anus, can become blocked, allowing bacteria to multiply and an abscess to form. After the abscess drains (surgically or spontaneously), the residual tract may fail to close and evolve into a fistula.

Other conditions that predispose to anal fistula include the following:

• Crohn's disease. Anal fistulas are extremely common in this chronic inflammatory bowel condition, occurring in 20 to 50 percent of affected patients. Crohn's-related fistulas tend to be complex, multi-branched, treatment-resistant, and closely tied to disease activity.
• Tuberculosis. In regions where tuberculosis is endemic, infection of the anal region with Mycobacterium tuberculosis can cause fistula formation. These cases require antitubercular therapy in addition to surgical management.
• Trauma and surgery. Surgical procedures in the anal region, obstetric tears during delivery (particularly third- and fourth-degree perineal lacerations), and direct injury can create the conditions for fistula formation.
• Radiation therapy. Pelvic radiotherapy impairs tissue perfusion and can lead to fistula development. Rectovaginal fistula is one of the most commonly seen consequences of this mechanism.
• Hidradenitis suppurativa. This chronic inflammatory skin condition primarily affects the apocrine sweat glands in the axillae, groin, and anogenital region, and fistula formation is a frequent complication.
• Diverticulitis. Infection and inflammation arising from diverticula in the colon can lead to fistula formation between the bowel and the skin, or between the bowel and adjacent organs.
• Cancer and chemotherapy. Anal or rectal cancer can directly cause fistula formation, and both chemotherapy and radiation therapy used in treatment can contribute to fistula development as a side effect.

Risk Factors

Several factors are associated with an increased likelihood of developing an anal fistula:

• Previous anal abscess. This is the strongest single risk factor. Approximately 40 to 50 percent of anal abscesses progress to fistula. The larger the abscess and the longer it goes untreated, the higher the risk.
• Crohn's disease. Between 20 and 50 percent of patients with Crohn's disease develop anal fistulas. In this group, fistulas follow a far more complex course and recur far more frequently.
• Male sex. Anal fistulas are two to three times more common in men than in women. The reason is not fully understood but is thought to relate to anatomical differences in the distribution of anal glands.
• Diabetes. Elevated blood sugar impairs immune function and reduces the body's capacity to fight infection. Anal abscesses and fistulas in diabetic individuals tend to be more frequent and more severe.
• Immunosuppression. HIV infection, post-transplant immunosuppressive therapy, and chronic corticosteroid use all increase susceptibility to infection and impaired healing.
• Chronic constipation. Hard stools can irritate the anal glands and increase infection risk.

Diagnosis

An anal fistula can often be diagnosed on clinical examination alone, but accurately mapping the fistula tract and evaluating complex cases may require advanced imaging.

Diagnostic methods include the following:

• Physical examination and proctological assessment. The foundation of diagnosis. External inspection of the perianal skin looks for the external opening, discharge, and swelling. Digital rectal examination may reveal the firmness and direction of the fistula tract. Goodsall's rule, a well-known anatomical guide, provides a preliminary indication of where the internal opening is likely to be based on the position of the external opening.
• Proctoscopy and anoscopy. Direct visualization of the inner surface of the anus to identify the internal opening. These procedures can typically be performed in an outpatient setting and are not highly painful.
• Magnetic resonance imaging (MRI). The gold standard for fistula classification. MRI provides detailed images of the fistula's relationship to the sphincter muscles, its secondary branches, and any collections of pus. It is indispensable for preoperative planning in complex, recurrent, or Crohn's-related fistulas. Its superior soft-tissue resolution and absence of ionizing radiation make it the preferred imaging modality.
• Endoanal ultrasonography. A specialized ultrasound probe placed inside the anus to visualize the sphincter muscles and fistula tract. It can be used as an alternative or complement to MRI, particularly for superficial fistulas and in guiding surgical decisions.
• Fistulography. Contrast material is injected into the fistula tract and an X-ray is taken to outline its path. Its use has declined with the widespread availability of MRI, but it can provide supplementary information in certain complex cases.
• Examination under anaesthesia (EUA). Allows thorough rectal examination while the patient is anaesthetized. Used for both diagnosis and simultaneous interventions such as seton placement. Particularly useful when pain prevents adequate clinical examination.

Treatment

An anal fistula will not close without treatment. The central challenge of management is to eliminate the fistula tract while preserving the sphincter muscles and protecting continence — two goals that can be difficult to reconcile simultaneously, particularly in complex fistulas.

Treatment options include the following:

• Fistulotomy. The simplest and most effective technique for suitable cases. The skin and tissue overlying the fistula tract are cut along its entire length, laying it open to heal from the inside out by granulation. It is the preferred approach for superficial fistulas that do not involve the sphincter muscles, with success rates above 90 percent. It is not used alone for fistulas that pass through a significant portion of the sphincter, due to the risk of incontinence.
• Seton placement. A thread or rubber band (seton) is passed through the fistula tract and tied outside. It serves two distinct purposes. A cutting seton is gradually tightened over time, slowly dividing the sphincter muscle while allowing scar tissue to form progressively, minimizing functional loss. A draining seton is left loose; it controls infection, keeps the tract open, and acts as a bridge to a definitive procedure. Setons are frequently used in complex fistulas and high-risk patients.
• LIFT procedure (ligation of intersphincteric fistula tract). The fistula tract is ligated and divided in the intersphincteric plane, closing it without causing direct sphincter injury. It is gaining increasing favor for transsphincteric fistulas and has produced encouraging results.
• Advancement flap procedure. The internal opening of the fistula is closed and covered with a flap of rectal mucosa or full-thickness rectal wall. It spares the sphincter and can be applied to complex fistulas and Crohn's cases, though success rates are more variable than those of fistulotomy.
• Fibrin glue and anal fistula plug. The tract is filled with fibrin glue or occluded with a bioabsorbable plug. These are minimally invasive options with no sphincter damage risk. However, success rates are lower than those of surgical approaches and recurrence is common. They may be considered in selected patients, particularly those with Crohn's-related fistulas or high surgical risk.
• Video-assisted anal fistula treatment (VAAFT). A small fistuloscope is introduced into the tract for direct internal visualization, and the tract wall is destroyed from within using electrocautery or laser. It is minimally invasive with a low risk of sphincter damage.
• Laser fistula treatment (FiLaC). Laser energy is delivered inside the fistula tract through a radially emitting fiber, destroying the tract lining. It is a sphincter-sparing minimally invasive technique with promising medium-term results.
• Medical treatment for Crohn's fistulas. In Crohn's-related fistulas, medical therapy is as important as surgery. Biologic agents (anti-TNF drugs such as infliximab and adalimumab) promote fistula closure and are a cornerstone of management. Antibiotics such as metronidazole and ciprofloxacin help control infection. Immunomodulators (azathioprine, 6-mercaptopurine) support long-term remission.

Complications

Untreated or inadequately treated anal fistulas can lead to a range of complications:

• Recurrent abscesses. As long as the fistula tract remains open, infection recurs and new abscesses form. Each new episode causes further tissue damage and makes subsequent treatment more challenging.
• Increasing complexity. Untreated fistulas can develop new branches and extend progressively deeper through the sphincter muscles. A fistula that was initially simple may transform into a highly complex horseshoe fistula over time.
• Fecal incontinence. Loss of sphincter muscle integrity (from the disease itself or from surgery) can result in difficulty controlling bowel movements. Minimizing this risk is one of the most important considerations in choosing a surgical approach.
• Sepsis and necrotizing infection. Uncontrolled or overlooked infection can spread rapidly and develop into Fournier's gangrene (necrotizing fasciitis of the anogenital region), a life-threatening emergency.
• Anal cancer. Long-standing untreated chronic anal fistulas (particularly Crohn's-related ones) carry a small but recognized risk of malignant transformation. This risk, though low, underlines the importance of ongoing surveillance in longstanding fistulas.
• Psychological and social impact. Chronic discharge, odor, and pain can profoundly affect social life, professional functioning, and mental health. Addressing this dimension alongside the physical aspects of treatment improves overall outcomes.

Living with Anal Fistula

With the right treatment plan and careful attention to daily habits, both recovery and long-term quality of life can be meaningfully improved for people with an anal fistula.

Postoperative Care

Keeping the wound area clean and dry promotes healing after surgery. Sitz baths (sitting in a shallow bath of warm water) once or twice a day both cleanse the wound and relieve discomfort. Use soft, clean cotton cloths to pat dry gently; avoid rough paper towels. Your surgeon will provide detailed wound care instructions — following them precisely reduces the risk of complications.

Diet and Bowel Habits

A fiber-rich diet softens stools and makes bowel movements easier. Hard stools can damage healing tissue and worsen pain. Drinking at least 8 to 10 glasses of water daily alongside increasing your intake of vegetables, fruit, whole grains, and legumes helps prevent constipation and supports recovery. Remember that increasing fiber without increasing fluid intake can make constipation worse. A short course of stool softeners or laxatives may be recommended by your doctor if needed.

Hygiene

Gently clean the anal area with soap and water after every bowel movement. Avoid moist wipes and perfumed products, which can irritate the skin. Wear loose-fitting, breathable cotton underwear and change it daily while discharge continues. Tight clothing can worsen itching and irritation.

Pain Management

Take the pain relievers prescribed by your surgeon regularly in the postoperative period. Sitz baths provide meaningful relief and can be repeated several times a day for 10 to 15 minutes at a time. If pain increases unexpectedly or is accompanied by fever, contact your doctor; this may indicate developing infection.

Managing the Underlying Condition

If an underlying condition such as Crohn's disease is present, its active management is essential for reducing fistula recurrence. Take all prescribed medications consistently and maintain your gastroenterology follow-up appointments without interruption.

Regular Follow-up

The risk of recurrence after anal fistula treatment should not be underestimated. Attending all follow-up appointments as scheduled allows your surgeon to monitor healing and catch any early signs of recurrence. If you notice new discharge, pain, or swelling, do not wait for your next appointment; seek prompt evaluation.

Preparing for Your Appointment

Coming prepared to your appointment helps your doctor make an accurate assessment more efficiently and ensures the most relevant information is available.

What you can do:

• Note when symptoms began and how they have evolved
• If you have previously had an anal abscess or fistula, describe what treatment was performed and what the outcome was
• Mention any diagnosis of Crohn's disease, tuberculosis, or other bowel conditions
• List all current medications (particularly immunosuppressants and biologic agents)
• Mention diabetes or any other chronic condition that affects your immune system
• Write down your questions in advance

Questions you may wish to ask your doctor:

• Is my fistula simple or complex?
• Are my sphincter muscles at risk?
• Which surgical approach do you recommend and why?
• Could my continence (bowel control) be affected?
• How does my Crohn's disease affect the treatment plan?
• How long will recovery take?
• What is the risk of recurrence and what can I do to reduce it?
• When can I return to work and normal activities?

Questions your doctor may ask:

• How long have you had these symptoms and how did they begin?
• Have you previously had an anal abscess or fistula?
• Is there discharge? If so, what does it look like?
• Do you have fever or a general feeling of being unwell?
• Do you have Crohn's disease or another inflammatory bowel condition?
• Do you have diabetes or any condition that affects your immune system?
• What medications are you currently taking?
• Have you had any pelvic surgery or radiotherapy in the past?